In Vivo Bioluminescence Imaging System Market Report – Research, Industry Analysis Reports and Market Demands

Global In Vivo Bioluminescence Imaging System Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report

Buy now

Table of Content

1 Market Overview

1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
- 1.3.1 Overview: Global In Vivo Bioluminescence Imaging System Consumption Value by Type: 2021 Versus 2025 Versus 2032
- 1.3.2 -20°C Class
- 1.3.3 -40°C Class
- 1.3.4 -80°C Class
- 1.3.5 Below -90°C
1.4 Market Analysis by Imaging Technology
- 1.4.1 Overview: Global In Vivo Bioluminescence Imaging System Consumption Value by Imaging Technology: 2021 Versus 2025 Versus 2032
- 1.4.2 Optical Imaging
- 1.4.3 MRI
- 1.4.4 Ultrasound
- 1.4.5 Others
1.5 Market Analysis by Imaging Mode
- 1.5.1 Overview: Global In Vivo Bioluminescence Imaging System Consumption Value by Imaging Mode: 2021 Versus 2025 Versus 2032
- 1.5.2 Single Bioluminescence Imaging System
- 1.5.3 Multimodal Imaging System
1.6 Market Analysis by Application
- 1.6.1 Overview: Global In Vivo Bioluminescence Imaging System Consumption Value by Application: 2021 Versus 2025 Versus 2032
- 1.6.2 Laboratory
- 1.6.3 Pet Hospital and Clinic
1.7 Global In Vivo Bioluminescence Imaging System Market Size & Forecast
- 1.7.1 Global In Vivo Bioluminescence Imaging System Consumption Value (2021 & 2025 & 2032)
- 1.7.2 Global In Vivo Bioluminescence Imaging System Sales Quantity (2021-2032)
- 1.7.3 Global In Vivo Bioluminescence Imaging System Average Price (2021-2032)

2 Manufacturers Profiles

3 Competitive Environment: In Vivo Bioluminescence Imaging System by Manufacturer

3.1 Global In Vivo Bioluminescence Imaging System Sales Quantity by Manufacturer (2021-2026)
3.2 Global In Vivo Bioluminescence Imaging System Revenue by Manufacturer (2021-2026)
3.3 Global In Vivo Bioluminescence Imaging System Average Price by Manufacturer (2021-2026)
3.4 Market Share Analysis (2025)
- 3.4.1 Producer Shipments of In Vivo Bioluminescence Imaging System by Manufacturer Revenue ($MM) and Market Share (%): 2025
- 3.4.2 Top 3 In Vivo Bioluminescence Imaging System Manufacturer Market Share in 2025
- 3.4.3 Top 6 In Vivo Bioluminescence Imaging System Manufacturer Market Share in 2025
3.5 In Vivo Bioluminescence Imaging System Market: Overall Company Footprint Analysis
- 3.5.1 In Vivo Bioluminescence Imaging System Market: Region Footprint
- 3.5.2 In Vivo Bioluminescence Imaging System Market: Company Product Type Footprint
- 3.5.3 In Vivo Bioluminescence Imaging System Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

4.1 Global In Vivo Bioluminescence Imaging System Market Size by Region
- 4.1.1 Global In Vivo Bioluminescence Imaging System Sales Quantity by Region (2021-2032)
- 4.1.2 Global In Vivo Bioluminescence Imaging System Consumption Value by Region (2021-2032)
- 4.1.3 Global In Vivo Bioluminescence Imaging System Average Price by Region (2021-2032)
4.2 North America In Vivo Bioluminescence Imaging System Consumption Value (2021-2032)
4.3 Europe In Vivo Bioluminescence Imaging System Consumption Value (2021-2032)
4.4 Asia-Pacific In Vivo Bioluminescence Imaging System Consumption Value (2021-2032)
4.5 South America In Vivo Bioluminescence Imaging System Consumption Value (2021-2032)
4.6 Middle East & Africa In Vivo Bioluminescence Imaging System Consumption Value (2021-2032)

5 Market Segment by Type

5.1 Global In Vivo Bioluminescence Imaging System Sales Quantity by Type (2021-2032)
5.2 Global In Vivo Bioluminescence Imaging System Consumption Value by Type (2021-2032)
5.3 Global In Vivo Bioluminescence Imaging System Average Price by Type (2021-2032)

6 Market Segment by Application

6.1 Global In Vivo Bioluminescence Imaging System Sales Quantity by Application (2021-2032)
6.2 Global In Vivo Bioluminescence Imaging System Consumption Value by Application (2021-2032)
6.3 Global In Vivo Bioluminescence Imaging System Average Price by Application (2021-2032)

7 North America

7.1 North America In Vivo Bioluminescence Imaging System Sales Quantity by Type (2021-2032)
7.2 North America In Vivo Bioluminescence Imaging System Sales Quantity by Application (2021-2032)
7.3 North America In Vivo Bioluminescence Imaging System Market Size by Country
- 7.3.1 North America In Vivo Bioluminescence Imaging System Sales Quantity by Country (2021-2032)
- 7.3.2 North America In Vivo Bioluminescence Imaging System Consumption Value by Country (2021-2032)
- 7.3.3 United States Market Size and Forecast (2021-2032)
- 7.3.4 Canada Market Size and Forecast (2021-2032)
- 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

8.1 Europe In Vivo Bioluminescence Imaging System Sales Quantity by Type (2021-2032)
8.2 Europe In Vivo Bioluminescence Imaging System Sales Quantity by Application (2021-2032)
8.3 Europe In Vivo Bioluminescence Imaging System Market Size by Country
- 8.3.1 Europe In Vivo Bioluminescence Imaging System Sales Quantity by Country (2021-2032)
- 8.3.2 Europe In Vivo Bioluminescence Imaging System Consumption Value by Country (2021-2032)
- 8.3.3 Germany Market Size and Forecast (2021-2032)
- 8.3.4 France Market Size and Forecast (2021-2032)
- 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
- 8.3.6 Russia Market Size and Forecast (2021-2032)
- 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

9.1 Asia-Pacific In Vivo Bioluminescence Imaging System Sales Quantity by Type (2021-2032)
9.2 Asia-Pacific In Vivo Bioluminescence Imaging System Sales Quantity by Application (2021-2032)
9.3 Asia-Pacific In Vivo Bioluminescence Imaging System Market Size by Region
- 9.3.1 Asia-Pacific In Vivo Bioluminescence Imaging System Sales Quantity by Region (2021-2032)
- 9.3.2 Asia-Pacific In Vivo Bioluminescence Imaging System Consumption Value by Region (2021-2032)
- 9.3.3 China Market Size and Forecast (2021-2032)
- 9.3.4 Japan Market Size and Forecast (2021-2032)
- 9.3.5 South Korea Market Size and Forecast (2021-2032)
- 9.3.6 India Market Size and Forecast (2021-2032)
- 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
- 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

10.1 South America In Vivo Bioluminescence Imaging System Sales Quantity by Type (2021-2032)
10.2 South America In Vivo Bioluminescence Imaging System Sales Quantity by Application (2021-2032)
10.3 South America In Vivo Bioluminescence Imaging System Market Size by Country
- 10.3.1 South America In Vivo Bioluminescence Imaging System Sales Quantity by Country (2021-2032)
- 10.3.2 South America In Vivo Bioluminescence Imaging System Consumption Value by Country (2021-2032)
- 10.3.3 Brazil Market Size and Forecast (2021-2032)
- 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

11.1 Middle East & Africa In Vivo Bioluminescence Imaging System Sales Quantity by Type (2021-2032)
11.2 Middle East & Africa In Vivo Bioluminescence Imaging System Sales Quantity by Application (2021-2032)
11.3 Middle East & Africa In Vivo Bioluminescence Imaging System Market Size by Country
- 11.3.1 Middle East & Africa In Vivo Bioluminescence Imaging System Sales Quantity by Country (2021-2032)
- 11.3.2 Middle East & Africa In Vivo Bioluminescence Imaging System Consumption Value by Country (2021-2032)
- 11.3.3 Turkey Market Size and Forecast (2021-2032)
- 11.3.4 Egypt Market Size and Forecast (2021-2032)
- 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
- 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

12.1 In Vivo Bioluminescence Imaging System Market Drivers
12.2 In Vivo Bioluminescence Imaging System Market Restraints
12.3 In Vivo Bioluminescence Imaging System Trends Analysis
12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

13.1 Raw Material of In Vivo Bioluminescence Imaging System and Key Manufacturers
13.2 Manufacturing Costs Percentage of In Vivo Bioluminescence Imaging System
13.3 In Vivo Bioluminescence Imaging System Production Process
13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
14.2 In Vivo Bioluminescence Imaging System Typical Distributors
14.3 In Vivo Bioluminescence Imaging System Typical Customers

15 Research Findings and Conclusion

16 Appendix

16.1 Methodology
16.2 Research Process and Data Source

Description

According to our (Global Info Research) latest study, the global In Vivo Bioluminescence Imaging System market size was valued at US$ 126 million in 2025 and is forecast to a readjusted size of US$ 190 million by 2032 with a CAGR of 6.2% during review period.
An in vivo bioluminescence imaging system is a scientific research instrument that utilizes bioluminescent reactions to perform non-invasive imaging of cells, genes, tumors, pathogens, or drug-action processes within living animals. Typically, this is achieved by inoculating experimental animals with cells expressing luciferase—or by creating animal models carrying a luciferase reporter gene—and subsequently injecting a corresponding substrate, such as luciferin; a high-sensitivity CCD or CMOS camera then captures the faint light signals generated in vivo. This system enables the continuous monitoring of disease progression, tumor growth, metastasis, infection dissemination, gene expression, and therapeutic responses without the need to euthanize the animals. It is widely employed in animal-based experimental research across fields such as oncology, immunology, infectious disease studies, drug screening, gene therapy, and regenerative medicine.
In vivo bioluminescence imaging system constitute a niche, high-margin product category within the realm of high-end scientific instrumentation. Demand primarily stems from animal experimentation scenarios involving oncology, infectious diseases, immunology, efficacy evaluation, gene expression analysis, and drug screening. Key competitive differentiators for these systems include high-sensitivity CCD/CMOS cameras, specialized dark-box optical designs, low-noise imaging capabilities, integrated animal anesthesia and temperature control, high-throughput multi-animal imaging, and advanced quantitative analysis software. The gross profit margin for in vivo bioluminescence imaging systems stands at approximately 38%.
The average selling price for an in vivo bioluminescence imaging system is $207.9k per unit, with a sales volume of 588 units against a total production capacity of 850 units.
The core significance of in vivo bioluminescence imaging systems lies in transforming traditional "endpoint-based animal experiments" into a process of "continuous, dynamic, and visualized monitoring." This capability allows for the repeated tracking of tumor burden, infection dissemination, cell migration, and drug responses within the same individual animal, thereby reducing the number of animals required for research and enhancing the consistency of experimental data. Although this market does not involve mass-market, widely popularized instrumentation, it faces strong, inelastic demand within the fields of pharmaceutical R&D, translational medicine, and high-level scientific research platforms. Consequently, customers prioritize imaging sensitivity, signal-to-noise ratio, quantitative stability, and software algorithms over the mere cost of the equipment itself. Future market competition is expected to gradually shift from a focus on hardware specifications to a contest of comprehensive solutions—encompassing "equipment + reagents + animal models + data analysis services." Manufacturers capable of providing robust methodological support and long-term after-sales service are best positioned to gain recognition and acceptance from universities, hospitals, CROs, and pharmaceutical companies.
This report is a detailed and comprehensive analysis for global In Vivo Bioluminescence Imaging System market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global In Vivo Bioluminescence Imaging System market size and forecasts, in consumption value ($ Million), sales quantity (Units), and average selling prices (K US$/Unit), 2021-2032
Global In Vivo Bioluminescence Imaging System market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Units), and average selling prices (K US$/Unit), 2021-2032
Global In Vivo Bioluminescence Imaging System market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Units), and average selling prices (K US$/Unit), 2021-2032
Global In Vivo Bioluminescence Imaging System market shares of main players, shipments in revenue ($ Million), sales quantity (Units), and ASP (K US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for In Vivo Bioluminescence Imaging System
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global In Vivo Bioluminescence Imaging System market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Perkin Elmer, Canon Medical Systems, Bruker, Idexx Laboratories, Hallmarq Veterinary Imaging, Huantong Nuclear Magnet, Sunny Optical, Photon, MILABS, IThera Medical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
In Vivo Bioluminescence Imaging System market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
-20°C Class
-40°C Class
-80°C Class
Below -90°C
Market segment by Imaging Technology
Optical Imaging
MRI
Ultrasound
Others
Market segment by Imaging Mode
Single Bioluminescence Imaging System
Multimodal Imaging System
Market segment by Application
Laboratory
Pet Hospital and Clinic
Major players covered
Perkin Elmer
Canon Medical Systems
Bruker
Idexx Laboratories
Hallmarq Veterinary Imaging
Huantong Nuclear Magnet
Sunny Optical
Photon
MILABS
IThera Medical
Vieworks
Aspect Imaging
TOMOWAVE
Trifoil Imaging
Clinx
Raylight
Spectral Instruments Imaging
Novel Medical
Tanon
Biolight
PINGSENG Healthcare
Fujifilm Visualsonics
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe In Vivo Bioluminescence Imaging System product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of In Vivo Bioluminescence Imaging System, with price, sales quantity, revenue, and global market share of In Vivo Bioluminescence Imaging System from 2021 to 2026.
Chapter 3, the In Vivo Bioluminescence Imaging System competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the In Vivo Bioluminescence Imaging System breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and In Vivo Bioluminescence Imaging System market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of In Vivo Bioluminescence Imaging System.
Chapter 14 and 15, to describe In Vivo Bioluminescence Imaging System sales channel, distributors, customers, research findings and conclusion.

Buy now